Your address will show here +12 34 56 78
  • Text Hover
Let's Accelerate
a Novel Therapeutic
for COVID-19
AVEX Impact is the nonprofit arm of AEVOLVE AG, a project designed to accelerate the pace of innovation in the health space. AVEX Impact was designed to nurture a spirit of community, participation, and purpose—to further the objectives and reach of AEVOLVE AG’s supported technologies.

As the COVID-19 pandemic continues to deepen its effect on the world’s health and economic climate, the AVEX Impact as a nonprofit organization is playing a major role in ensuring that the innovations in health technology are within reach of those who need it most, instituting programs of relevance that benefit both promising COVID-19 medical solutions and patients.
AVEX Impact is the nonprofit arm of AEVOLVE AG, a project designed to accelerate the pace of innovation in the health space. AVEX Impact was designed to nurture a spirit of community, participation, and purpose—to further the objectives and reach of AEVOLVE AG’s supported technologies.

AVEX Impact was designed to nurture a spirit of community, 
AEVOLVE SUPPORTS NUCISION
NuCISION’s technology proposes a new antiviral model that opens up a new approach towards beating the virus. It is developing a novel cell-penetrating programmable enzyme-based anti-viral model to directly address SARS-CoV-2. 

This new medical technology, which is a departure from antibody or vaccine approaches, is expected to enter human trials by Q4 2021.

It is developing a novel cell-penetrating programmable enzyme-based anti-viral model to directly address SARS-CoV-2. 

DONATE TO MAKE THIS HAPPEN

Learn more about:
  • Text Hover
  • Text Hover
The Aevolve AG Website serves for information purposes only and does not constitute research. This site and all materials, documents and information used therein or distributed in the context of its publication do not constitute or form part of and should not be construed as, an offer (public or private) or a solicitation of offers (public or private) to purchase or subscribe for or sell shares or other securities of the Company or any of its affiliates or subsidiaries in any jurisdiction or an inducement to enter into investment activity in any jurisdiction, and may not be used for such purposes.

This website may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Aevolve AG or any of its affiliates or subsidiaries and those explicitly or implicitly presumed in these statements.

These factors include, but are not limited to: (1) general market, macroeconomic, governmental and regulatory trends, (2) movements in securities markets, exchange rates and interest rates and (3) other risks and uncertainties inherent in our business. Against the background of these uncertainties, you should not rely on forwardlooking statements. Neither the Company nor any of its affiliates or subsidiaries or their respective bodies, executives, employees and advisers assume any responsibility to prepare or disseminate any supplement, amendment, update or revision to any of the information, opinions or forward-looking statements contained in this website or to adapt them to any change in events, conditions or circumstances, except as required by applicable law or regulation.

Any - including only partial - reproduction of any article or picture included in this website is solely permitted based on an authorization from Aevolve AG. No responsibility is assumed in case of unsolicited delivery.

© Aevolve AG 2019. All rights reserved.